Novartis, Roxane Settle Famvir Dispute

Law360, New York (June 15, 2011, 5:20 PM EDT) -- Novartis Pharmaceuticals Corp. and Roxane Laboratories Inc. have agreed to settle a New Jersey suit accusing the generics maker of infringing three Novartis patents in an effort to release a form of the herpes treatment Famvir, according to documents filed Monday.

U.S. District Judge Jose L. Linares issued two orders acknowledging the settlement and denying all pending motions for summary judgment in the case. His orders did not give any details about the settlement and the parties have not filed any joint motions seeking dismissal of...
To view the full article, register now.